MFN2 and metabolic dysfunction-associated steatohepatitis: All these conditions exposed so far are due to a reduction in Mfn2 hepatic levels, leading to a poor PS transfer and phospholipid synthesis, which causes ER stress, a NASH-like phenotype, and liver cancer.